CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. FIRST...Lease • December 19th, 2025 • Aktis Oncology, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 19th, 2025 Company IndustryTHIS FIRST AMENDMENT TO LEASE (this “First Amendment”) is made and entered into as of February 1, 2023 (“First Amendment Effective Date”), by and between IDB 17-19 DRYDOCK LIMITED PARTNERSHIP, a Delaware Limited Partnership (“Landlord”) and AKTIS ONCOLOGY, INC., a Delaware corporation (“Tenant”).
CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. FIRST...Lease • November 22nd, 2024 • Aktis Oncology, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 22nd, 2024 Company IndustryTHIS FIRST AMENDMENT TO LEASE (this “First Amendment”) is made and entered into as of February 1, 2023 (“First Amendment Effective Date”), by and between IDB 17-19 DRYDOCK LIMITED PARTNERSHIP, a Delaware Limited Partnership (“Landlord”) and AKTIS ONCOLOGY, INC., a Delaware corporation (“Tenant”).